首页> 外文期刊>Frontiers in Life Science >Traditional fermentation of Ayurvedic medicine yields higher proinflammatory enzyme inhibition compared to wine-model product
【24h】

Traditional fermentation of Ayurvedic medicine yields higher proinflammatory enzyme inhibition compared to wine-model product

机译:与葡萄酒模型产品相比,阿育吠陀医学的传统发酵产生更高的促炎酶抑制作用

获取原文
           

摘要

This study investigated the process of preparing fermented medicines as prescribed in Ayurveda, the traditional Indian system of medicine. Berberine, an alkaloid, was used as a model compound. Berberine is the active constituent of Berberis aristata and is alleged to have anti-inflammatory effect. Biotransformation of berberine was studied by the phospholipase A_(2) assay in fermented products prepared in traditional and commercially available brewer's yeast-induced environments. Sugar and alcohol levels were estimated to indicate the culmination of fermentation. It was confirmed that traditional fermentation biotransforms berberine to a greater extent than commercially available brewer's yeast-induced fermentation. Therefore, fermentation induced by commercially available yeast is no substitute for the ethnopharmacological and traditional fermentation prescribed in the traditional Indian system of medicine.
机译:这项研究调查了印度传统医学体系阿育吠陀规定的发酵药物的制备过程。小ber碱,一种生物碱,用作模型化合物。小ber碱是小Ber小active的活性成分,据称具有抗炎作用。通过磷脂酶A_(2)分析研究了黄连素的生物转化,在传统的和市售的啤酒酵母诱导的环境中制备的发酵产品中。估计糖和酒精含量表明发酵达到顶点。已经证实,与商业上可利用的啤酒酵母诱导的发酵相比,传统的发酵在更大程度上生物转化了小ber碱。因此,由市售酵母诱导的发酵不能替代传统印度医学体系中规定的民族药理学和传统发酵。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号